Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: Role of the glutathione redox cycle
Autor: | Patrícia Maciel, Andreia Teixeira-Castro, Marta Daniela Costa, Daniela Vilasboas-Campos, Carlos Bessa, Fabiano Guimarães Silva, Rejaine Rios, Alberto Carlos Pires Dias |
---|---|
Přispěvatelé: | Universidade do Minho |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Antioxidant Hyptis medicine.medical_treatment Glutathione reductase Pharmacology Biochemistry Neuroprotection Hyptis spp 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Physiology (medical) Hyptis suaveolens medicine Animals Caenorhabditis elegans Machado-Joseph disease/Spinocerebellar ataxia type 3 Science & Technology biology Plant Extracts Rosmarinic acid Glutathione biology.organism_classification Bioactive compound 3. Good health 030104 developmental biology chemistry Tauopathies Peptides Oxidation-Reduction 030217 neurology & neurosurgery |
Zdroj: | Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP |
ISSN: | 1873-4596 |
Popis: | Hyptis suaveolens (HS), Hyptis pectinata (HP) and Hyptis marrubioides (HM) are plants used in folk medicine for treatment of several diseases. Here, we tested the in vivo antioxidant and neuroprotective potential of methanolic extracts from these plants, containing several rosmarinic acid derivatives and isoquercetin. In C. elegans, HS, HP and HM leaf extracts enhanced the antioxidant responses through the induction of specific antioxidant enzymes and demonstrated neurotherapeutic potential in transgenic models of genetically determined human neurodegenerative diseases - frontotemporal dementia with parkinsonism linked to chromosome 17 and Machado-Joseph disease. Chronic treatment of disease models with HS, HP and HM leaf extracts improved the animals motor function and increased their tolerance to an oxidative insult. The restorative effect of HM extract in motor performance of both disease models required the presence of glutathione reductase (gsr-1), an enzyme that assures the glutathione redox cycle, highlighting the role of this pathway and unveiling a common candidate therapeutic target for these diseases. Our findings strengthen the relevance of plant-derived bioactive compound discovery for neurodegenerative disorders that remain without effective treatment. This work has been funded by ICVS Scientific Microscopy Platform, member of the national infrastructure PPBI - Portuguese Platform of Bioimaging (PPBI–POCI-01-0145-FEDER-022122; by National funds, through the Foundation for Science and Technology (FCT) - project UIDB/50026/2020, UIDP/50026/2020 and POCI-01-0145-FEDER0 31987; and by the projects NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). This work was supported by the “Contrato-Programa” UIDB/04050/2020 funded by national funds through the Foundation for Science and Technology (FCT). This work was supported by Federal Institute of Education, Science and Technology Goiano (IF Goiano). Costa, MD received funding from National Ataxia Foundation (NAF) and Vilasboas-Campos, D received a PhD grant from FCT (SFRH/BD/ 147,826/2019). info:eu-repo/semantics/publishedVersion |
Databáze: | OpenAIRE |
Externí odkaz: |